Quotient Biodiagnostics Signs Agreement to Supply Blood Bank Reagents to Blood Group Alliance (BGA)

BGA is a Buying Cooperative Representing 69 Independent Blood Center Members

December 13, 2010

NEWTOWN, PA (December 13, 2010 Quotient Biodiagnostics, Inc., dedicated to providing high quality immunohematology products to blood banks and hospitals, today announced that it has entered into a supply agreement with Blood Group Alliance (BGA). BGA will promote Quotient’s product line to its blood center member organizations, which account for over 50% percent of the nation’s transfusion requirements. The agreement includes Quotient’s first 24 products in its proprietary line of manual transfusion diagnostics as well as future products when approved by the U.S. Food & Drug Administration (FDA).

Get Answers Here